Phase I Clinical Trial of Pegylated Liposomal Doxorubicin and Docetaxel in Patients With Advanced Solid Tumors

2011 ◽  
Vol 34 (1) ◽  
pp. 27-31 ◽  
Author(s):  
Syma Iqbal ◽  
Denice D. Tsao-Wei ◽  
David I. Quinn ◽  
Barbara J. Gitlitz ◽  
Susan Groshen ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Solid Tumors ◽  
Liposomal Doxorubicin ◽  
Pegylated Liposomal Doxorubicin ◽  
Phase I Clinical Trial ◽  
Advanced Solid Tumors

Phase I clinical trial of temozolomide and methoxyamine (TRC-102) in patients with advanced solid tumors.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 2558-2558 ◽  
Author(s):  
Jennifer Rachel Eads ◽  
Smitha S. Krishnamurthi ◽  
Joel N. Saltzman ◽  
Neal J. Meropol ◽  
Joseph A. Bokar ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Solid Tumors ◽  
Phase I Clinical Trial ◽  
Advanced Solid Tumors

scholarly journals Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid Tumors

2015 ◽  
Vol 22 (6) ◽  
pp. 1364-1370 ◽  
Author(s):  
Melinda S. Merchant ◽  
Matthew Wright ◽  
Kristin Baird ◽  
Leonard H. Wexler ◽  
Carlos Rodriguez-Galindo ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Solid Tumors ◽  
Pediatric Patients ◽  
Phase I Clinical Trial ◽  
Advanced Solid Tumors

Safety and pharmacokinetics of intravenous VEGF Trap in a phase I clinical trial of patients with advanced solid tumors

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 3029-3029 ◽  
Author(s):  
J. Dupont ◽  
M. L. Rothenberg ◽  
D. R. Spriggs ◽  
J. M. Cedarbaum ◽  
E. S. Furfine ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Solid Tumors ◽  
Phase I Clinical Trial ◽  
Advanced Solid Tumors ◽  
Vegf Trap

Phase I clinical trial of VTX-2337, a selective toll-like receptor 8 (TLR8) agonist, in patients with advanced solid tumors.

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. 2537-2537 ◽  
Author(s):  
P. A. Cohen ◽  
D. W. Northfelt ◽  
G. J. Weiss ◽  
D. D. Von Hoff ◽  
K. Manjarrez ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Solid Tumors ◽  
Phase I Clinical Trial ◽  
Advanced Solid Tumors ◽  
Toll Like Receptor

Phase I clinical trial of the glutaminase inhibitor CB-839 plus capecitabine in patients with advanced solid tumors.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. 2562-2562 ◽  
Author(s):  
Jennifer Rachel Eads ◽  
Smitha S. Krishnamurthi ◽  
Joel N. Saltzman ◽  
David Lawrence Bajor ◽  
Shaveta Vinayak ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Solid Tumors ◽  
Phase I Clinical Trial ◽  
Advanced Solid Tumors

Phase I Study of Paclitaxel (Taxol) and Pegylated Liposomal Doxorubicin (Caelyx) Administered Every 2 Weeks in Patients with Advanced Solid Tumors

Oncology ◽  
2002 ◽  
Vol 62 (3) ◽  
pp. 216-222 ◽  
Author(s):  
D. Mavroudis ◽  
Ch. Kouroussis ◽  
S. Kakolyris ◽  
S. Agelaki ◽  
K. Kalbakis ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Liposomal Doxorubicin ◽  
Pegylated Liposomal Doxorubicin ◽  
Advanced Solid Tumors

scholarly journals Phase I Clinical Trial of Ds-7423, an Oral Pi3K/Mtor Dual Inhibitor, in Japanese Patients with Advanced Solid Tumors

2014 ◽  
Vol 25 ◽  
pp. iv153 ◽  
Author(s):  
T. Yokota ◽  
T. Tsushima ◽  
H. Kenmotsu ◽  
J. Watanabe ◽  
M. Endo ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Solid Tumors ◽  
Japanese Patients ◽  
Phase I Clinical Trial ◽  
Advanced Solid Tumors ◽  
Dual Inhibitor
Sign in / Sign up

Export Citation Format

Share Document